Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel

SIMPLE SUMMARY: In prostate cancer patients with rising prostate-specific antigens (PSAs) after primary local therapy, and at high risk of metastatic disease based on a high Gleason score or ISUP grades 4–5 and/or short PSA doubling time, androgen-deprivation therapy (ADT) was shown to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrot, Aurore, Elaidi, Reza-Thierry, Colomban, Olivier, Maillet, Denis, Tod, Michel, You, Benoit, Oudard, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834031/
https://www.ncbi.nlm.nih.gov/pubmed/35159082
http://dx.doi.org/10.3390/cancers14030815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834031/
https://www.ncbi.nlm.nih.gov/pubmed/35159082
http://dx.doi.org/10.3390/cancers14030815

Ejemplares similares